Company intelligence / Profile preview
Dana Pharmaceuticals
- Ownership
- Private
- Development stage
- Commercial
Overview
Dana Pharmaceuticals is a leading Nigerian pharmaceutical company with over 38 years of experience, manufacturing and marketing more than 60 products including oral dosage forms and large volume parenterals. The company operates three ISO 9001-certified plants, has a nationwide distribution network, and focuses on affordable healthcare. Its product range includes generics such as tablets, capsules, syrups, intravenous fluids, and flagship brands like Danacid Tablets/Suspension and Ferrodan Capsules/Tonic. No clinical trial data is reported as the focus is on generics rather than novel therapeutics.
- Therapeutic areas
- PulmonologyImmunologyHematologyGastroenterologyNeurologyInfectious Diseases
- Modalities
- Small moleculeBiologic (for infusion fluids)
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Dana Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dana Pharmaceuticals.